Clinical Trials
4 trialsNCT05099172 2026-05-13
First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)
Bayer
Phase 1/2 Active not recruiting
NCT06269133 2026-05-08
Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Patients
Regeneron Pharmaceuticals
Active not recruiting
NCT05215067 2025-03-12
A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer
Akeso
Phase 2 Active not recruiting
NCT04818333 2024-06-13
A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2 Active not recruiting